Cincinnati, Ohio (May 15, 2009) – HealthWarehouse.com, Inc., a privately held Delaware corporation, and Clacendix, Inc. (OTCBB: IONN.OB) announced today the completion of their business combination pursuant to a securities exchange agreement. The combined company will assume and execute the HealthWarehouse.com business plan as its sole business. In connection with the business combination, Clacendix intends to change its name to HealthWarehouse.com. Until the name change becomes effective, Clacendix shares will continue to be quoted on the OTC Bulletin Board under the ticker IONN.OB.
Under the securities exchange agreement, Clacendix acquired all the outstanding capital stock of HealthWarehouse.com from the existing stockholders of HealthWarehouse.com in exchange for newly-issued shares of Clacendix common stock. As a result of the share exchange, HealthWarehouse.com is now a wholly-owned subsidiary of Clacendix and the former HealthWarehouse.com stockholders will own, on a post-transaction basis, approximately 82.4% of the outstanding common stock of Clacendix. Prior to the close of the business combination, HealthWarehouse.com completed a financing, raising net proceeds of $1.2 million from accredited investors. Clacendix will file a Form 8-K on or before May 20, 2009, which will contain detailed business and financial information concerning the combined company.
HealthWarehouse.com, a licensed U.S. online mail-order pharmacy, is working to revolutionize the way Americans purchase prescription drugs and healthcare products. In addition to offering cost savings, HealthWarehouse.com seeks to enhance the consumer experience by providing exceptional customer service, convenience and privacy. With some of the lowest priced prescriptions in the United States, 100% free shipping and 90-day returns with no restocking fees, consumers have responded by making HealthWarehouse.com one of the fastest growing online pharmacies.
Clacendix CEO, Norman Corn said, “We are truly excited, having searched for a suitable business combination candidate for over a year. HealthWarehouse.com is growing at an incredible rate with an impressive business model that we believe delivers outstanding consumer value.”
Upon the close of the business combination, the company appointed Lalit Dhadphale as Chairman, President and CEO, in addition to his duties as a director of HealthWarehouse.com, he will now serve as director of the combined company. Patrick E. Delaney, Chief Financial Officer at Clacendix, will continue in the same role.
“This is a significant step forward for our company,” states CEO Lalit Dhadphale. “We are excited to leverage the public financial markets to fund expansion and further accelerate our strategy to deliver consumers a convenient and affordable option when purchasing prescription drugs in the United States.”
HealthWarehouse.com, Inc. is a licensed U.S. online mail-order pharmacy based in Cincinnati, Ohio. HealthWarehouse.com is the first company to offer FDA-approved generic prescriptions at $3.50 for 30-day supplies and $9.50 for 90-day supplies with 100% free shipping. HealthWarehouse.com’s mission is to redefine the meaning of healthcare and relentlessly strive to make it affordable for all Americans.
The information contained in this press release contains “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement is one which is based on current expectations of future events or conditions and does not relate to historical or current facts. These statements include various estimates, forecasts, projections of Clacendix’ future performance, statements of Clacendix’ plans and objectives, and other similar statements. Forward-looking statements include phrases such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “predicts,” “estimates,” “assumes,” “projects,” “may,” “will,” “will be,” “should,” or similar expressions. Although Clacendix believes that its current expectations are based on reasonable assumptions, it cannot assure you that the expectations contained in such forward-looking statements will be achieved. Forward-looking statements involve risks, uncertainties and assumptions which could cause actual results to differ materially from those contained in such statements. Investors should not place undue reliance on the forward-looking statements contained in this press release, as they speak only as of the date of this press release, and Clacendix expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statements contained herein.
Friday, May 15, 2009
Wednesday, May 13, 2009
Are your OneTouch test strips becoming harder to find and possibly increasing in price? Effective December 2008, Lifescan has made the decision to discontinue two of its OneTouch test strip products due to decline in demand. If you are using a OneTouch FastTake or One Touch Basic, II or Profile glucose meter, now may be the right time to look into upgrading your system.
LifeScan’s decision to cease the manufacturing of the two categories of OneTouch test strips was cited as a result of declining demand; it is not the result of any type of safety issue regarding the products. The final batch of FastTake test strips will have the expiry date of March 2010. Compatible strips for the other meters listed above, the expiration of these last test strips will be January 2010.
With the ever-present proliferation of counterfeit test strips, if you choose to continue shopping for these strips, please keep the noted expiration dates in mind. If you haven’t already switched, now is a great time to consider upgrading your meter and corresponding supplies; doing so will ensure the ease of sourcing your diabetic testing needs and potentially save you both time and money.
For additional questions related to LifeScan products, contact the U.S. Customer Service at: 1-800 227-8862